Forte Biosciences FBRX
FBRX
$76.99 +0.00 (+0.00%)
At close: Aug 28, 2026 · 4:00 PM EDT

Forte Biosciences (FBRX) Non Operating Interest Expenses (2016 - 2020)

Updated

Forte Biosciences (FBRX) posted Non Operating Interest Expenses of $756,000 for Q1 2020, up 0.3% from $754,000 a year earlier and up 129.1% from the prior quarter.

Analysis

Forte Biosciences (FBRX) Non Operating Interest Expenses (2016 - 2020) Analysis & Trends

For the trailing twelve months through Mar 31, 2020, Non Operating Interest Expenses at Forte Biosciences was $3.82 million, up 14.6% year-over-year; for FY2019, it was $3.82 million, up 30.4% from FY2018.

  • Annual Non Operating Interest Expenses shows a four-year compound annual growth rate of 83.2% (FY2015 to FY2019).
  • In prior years, Forte Biosciences' Non Operating Interest Expenses was $2.93 million in FY2018 (+51.7%), $1.93 million in FY2017 (-5.8%), $2.05 million in FY2016 (+505.3%) and $339,000 in FY2015.
  • Quarterly Non Operating Interest Expenses has run from a low of $330,000 in Q4 2019 to a high of $1.97 million in Q3 2019 over five years.
  • On a year-over-year basis, Non Operating Interest Expenses increased in six of the last eight quarters, with growth averaging 60.1%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q3 2019, with growth of 165.9%; the weakest was Q4 2019, with a decline of 55.8%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $330,000 (Q4 2019), $1.97 million (Q3 2019) and $764,000 (Q2 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Forte Biosciences 1.58 Bn 1.38 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 756,000.00
Dec 31, 2019 330,000.00
Sep 30, 2019 1.97 Mn
Jun 30, 2019 764,000.00
Mar 31, 2019 754,000.00
Dec 31, 2018 746,000.00
Sep 30, 2018 742,000.00
Jun 30, 2018 1.09 Mn
Mar 31, 2018 349,000.00
Dec 31, 2017 391,000.00
Sep 30, 2017 430,000.00
Jun 30, 2017 495,000.00
Mar 31, 2017 616,000.00
Dec 31, 2016 533,000.00
Sep 30, 2016 511,000.00
Jun 30, 2016 505,000.00
Mar 31, 2016 503,000.00
API Access

Forte Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=FBRX&period=max&api_key=YOUR_API_KEY